AzTrials
AzTrials

Dentin HypersensitivityNCT05927831

Grape Seed Extract VS Low Level Laser Therapy for Dentin Hypersensitivity

A study testing Grape Seed Extract and Low-level laser therapy in people with Dentin Hypersensitivity, run by Manipal University College Malaysia at 1 site in Malaysia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Dentin hypersensitivity (DH) is a common clinical problem frequently seen in dental patients. According to Splieth et al., the prevalence of dentin hypersensitivity is 3-98% in adult population.DH is described as a short, sharp pain or discomfort that responses to certain stimuli, typically thermal, tactile, osmotic… Read more about this study

Who is it for?
Ages 20 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Dentin Hypersensitivity
What is being tested?
Grape Seed Extract and Low-level laser therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteMalaysia
Study dates
15 May 2023to 15 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with at least three sensitive tooth by gingival recession or tooth wear >2 scores on the VAS scale.
  • Tooth wear index score <3 (Smith and Knight tooth wear index)
  • Systemically healthy patient.
  • 20-50 years of age.

Who cannot join

  • Teeth with caries, cracked teeth, mobile teeth and pulpitis.
  • Deep periodontal pockets (probing depth >6 mm), periodontal surgery within the previous 3 months.
  • Recent desensitizing therapy
  • systemic diseases and gastric diseases (GERD)
  • Allergy to active ingredients.

Trial locations and contacts

1 site in 1 country.

Malaysia1 site, 1 recruiting
  • Manipal University College Malaysia

    Melaka Tengah, Melaka, 75450

    Anchu R Thomas, +601127292297, rachel.thomas@manipal.edu.my

    Recruiting

Other trials in Malaysia

About this study

Official title: Comparison of the Effectiveness of Grape Seed Extract (GSE) and Low-level Laser Therapy in the Management of Dentin Hypersensitivity: A Randomized Control Trial

Dentin hypersensitivity (DH) is a common clinical problem frequently seen in dental patients. According to Splieth et al., the prevalence of dentin hypersensitivity is 3-98% in adult population.DH is described as a short, sharp pain or discomfort that responses to certain stimuli, typically thermal, tactile, osmotic or chemical, due to exposed dentinal surface which can be explained by the hydrodynamic theory.

The laser is a narrow, focused beam of light emitted to vaporise, fuse, melt, or seal dentinal tubules using laser heat to induce hydroxyapatite crystals for recrystallisation of the mineral component of dentine. The obliteration of dentinal tubules is caused by heat generated by laser beam which inhibits the transmission of the stimulus in the dentinal tubules.

Grape seed extract contains proanthocyanidins (PA) which is able to bind to proline-rich proteins, like collagen, and contributes in enzyme proline hydroxylase activity that is essential for the biosynthesis of collagen in the dentin. The cross-linking action of collagen fibrils in dentin also able to prevent mineral loss.

Being tested
Grape Seed Extract, Low-level laser therapy
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Grape Seed ExtractDrug

    Also called GSE

    Grape seed extract will be applied in the form of a gel on the tooth surface

  • Low-level laser therapyDevice

    The device will be set at a wavelength of 810 nm, with a power output of 0.5 watts tip of diameter 300 μ in non-contact mode

Study groups in NCT05927831
Study groupRoleWhat they receive
Grape seed extractExperimentalgrape seed extract with 95% proanthocyanins will be applied topically to the hypersensitive dentin area for 10 minutes, followed by rinsing with water.
Receives: Drug: Grape Seed Extract
Low-level laser therapyExperimentalThe low-level laser diode treatment of 810 nm will be performed using a commercially available diode laser device. The device will be set at a wavelength of 810 nm, with a power output of 0.5 watts tip of diameter 300 μ in non-contact mode starting at a distance of 5-6 mm away from the hypersensitive tooth area and slowly approaching within a distance of 2-3mm in a scanning motion covering the entire hypersensitive tooth area for a period of 30 seconds to 1 minute.
Receives: Device: Low-level laser therapy
Combination of low-level laser therapy and grape seed extractExperimentalGrape seed extract will be applied topically to the hypersensitive dentin area for 10 minutes, followed by low-level laser diode treatment.
Receives: Drug: Grape Seed Extract; Device: Low-level laser therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The patients' dentin hypersensitivity levels will be measured using a visual analogue scale (VAS)

    The patients' dentin hypersensitivity levels will be measured using a visual analogue scale (VAS)(0 to 10) before and after treatment.

    Measured: 1st day

  2. The patients' dentin hypersensitivity levels will be measured using a visual analogue scale (VAS)

    The patients' dentin hypersensitivity levels will be measured using a visual analogue scale (VAS)(0 to 10) after treatment.

    Measured: 3rd day

  3. The patients' dentin hypersensitivity levels will be measured using a visual analogue scale (VAS)

    The patients' dentin hypersensitivity levels will be measured using a visual analogue scale (VAS)(0 to 10) after treatment.

    Measured: 7th day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2023
  2. Study start15 May 2023
  3. Primary completion15 Jan 2024 (estimated)
  4. Study completion15 Jan 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05927831
Sponsor's protocol ID
018/2023
Status last verified
Jun 2023
First submitted
3 Jun 2023
Last updated
3 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ong TYD, Lim WN, Ong LJ, Lim JW, Kaur G, Thomas AR, Narasu VB. Comparison of the Effectiveness of Grape Seed Extract and Low-Level Laser Therapy in the Management of Dentin Hypersensitivity: A Randomized Controlled Trial. Scientifica (Cairo). 2026 Feb 12;2026:6656174. doi: 10.1155/sci5/6656174. eCollection 2026.

    PubMed 41696662

Questions about this trial

What is this clinical trial studying?

A study testing Grape Seed Extract and Low-level laser therapy in people with Dentin Hypersensitivity, run by Manipal University College Malaysia at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anchu R Thomas (+601127292297, rachel.thomas@manipal.edu.my), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The patients' dentin hypersensitivity levels will be measured using a visual analogue scale (VAS) (time frame: 1st day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05927831, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2023; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in